MX2019000769A - Formulacion topica para promover la curacion de heridas. - Google Patents
Formulacion topica para promover la curacion de heridas.Info
- Publication number
- MX2019000769A MX2019000769A MX2019000769A MX2019000769A MX2019000769A MX 2019000769 A MX2019000769 A MX 2019000769A MX 2019000769 A MX2019000769 A MX 2019000769A MX 2019000769 A MX2019000769 A MX 2019000769A MX 2019000769 A MX2019000769 A MX 2019000769A
- Authority
- MX
- Mexico
- Prior art keywords
- topical formulation
- wound healing
- promoting wound
- agent
- active agent
- Prior art date
Links
- 239000012049 topical pharmaceutical composition Substances 0.000 title abstract 2
- 230000001737 promoting effect Effects 0.000 title 1
- 230000029663 wound healing Effects 0.000 title 1
- 239000013543 active substance Substances 0.000 abstract 2
- ZIIAJIWLQUVGHB-UHFFFAOYSA-N Circimaritin Natural products C=1C(=O)C=2C(O)=C(OC)C(OC)=CC=2OC=1C1=CC=C(O)C=C1 ZIIAJIWLQUVGHB-UHFFFAOYSA-N 0.000 abstract 1
- WYQVAPGDARQUBT-FGWHUCSPSA-N Madecassol Chemical compound O([C@@H]1[C@@H](CO)O[C@H]([C@@H]([C@H]1O)O)OC[C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)OC(=O)[C@]12CC[C@H]([C@@H]([C@H]1C=1[C@@]([C@@]3(CC[C@H]4[C@](C)(CO)[C@@H](O)[C@H](O)C[C@]4(C)[C@H]3CC=1)C)(C)CC2)C)C)[C@@H]1O[C@@H](C)[C@H](O)[C@@H](O)[C@H]1O WYQVAPGDARQUBT-FGWHUCSPSA-N 0.000 abstract 1
- 230000000845 anti-microbial effect Effects 0.000 abstract 1
- 239000004599 antimicrobial Substances 0.000 abstract 1
- WYQVAPGDARQUBT-XCWYDTOWSA-N asiaticoside Natural products O=C(O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@H]2[C@H](O)[C@H](O)[C@H](O[C@H]3[C@H](O)[C@H](O)[C@@H](O)[C@H](C)O3)[C@@H](CO)O2)O1)[C@@]12[C@@H]([C@@H](C)[C@H](C)CC1)C=1[C@](C)([C@@]3(C)[C@@H]([C@@]4(C)[C@H]([C@@](CO)(C)[C@@H](O)[C@H](O)C4)CC3)CC=1)CC2 WYQVAPGDARQUBT-XCWYDTOWSA-N 0.000 abstract 1
- 229940022757 asiaticoside Drugs 0.000 abstract 1
- QCYLIQBVLZBPNK-UHFFFAOYSA-N asiaticoside A Natural products O1C(C(=O)C(C)C)=CC(C)C(C2(C(OC(C)=O)CC34C5)C)C1CC2(C)C3CCC(C1(C)C)C45CCC1OC1OCC(O)C(O)C1O QCYLIQBVLZBPNK-UHFFFAOYSA-N 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- OBQMAEGCYPFNKQ-UHFFFAOYSA-N cirsimaritin Natural products COc1c(C)cc2OC(=CC(=O)c2c1O)c3ccc(O)cc3 OBQMAEGCYPFNKQ-UHFFFAOYSA-N 0.000 abstract 1
- 239000003995 emulsifying agent Substances 0.000 abstract 1
- 239000003883 ointment base Substances 0.000 abstract 1
- 239000003755 preservative agent Substances 0.000 abstract 1
- 230000002335 preservative effect Effects 0.000 abstract 1
- QCDYOIZVELGOLZ-UHFFFAOYSA-N salvigenin Chemical compound C1=CC(OC)=CC=C1C1=CC(=O)C2=C(O)C(OC)=C(OC)C=C2O1 QCDYOIZVELGOLZ-UHFFFAOYSA-N 0.000 abstract 1
- ZZPHAQJIENBZOF-UHFFFAOYSA-N salvigenin Natural products COc1c(C)cc2OC(=CC(=O)c2c1O)c3ccc(C)cc3 ZZPHAQJIENBZOF-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7024—Esters of saccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/532—Agastache, e.g. giant hyssop
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D11/00—Solvent extraction
- B01D11/02—Solvent extraction of solids
- B01D11/028—Flow sheets
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D11/00—Solvent extraction
- B01D11/02—Solvent extraction of solids
- B01D11/0288—Applications, solvents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Dermatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Molecular Biology (AREA)
- Dispersion Chemistry (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
La presente invención proporciona una formulación tópica que comprende un agente activo, un agente que aumenta la viscosidad, una base de ungüento, un conservante antimicrobiano y un agente emulsionante, en donde el agente activo comprende salvigenina y opcionalmente asiaticósido.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662363284P | 2016-07-17 | 2016-07-17 | |
| PCT/CN2017/093118 WO2018014805A1 (en) | 2016-07-17 | 2017-07-17 | Topical formulation for promoting wound healing |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2019000769A true MX2019000769A (es) | 2019-09-19 |
| MX385380B MX385380B (es) | 2025-03-18 |
Family
ID=60942314
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2019000769A MX385380B (es) | 2016-07-17 | 2017-07-17 | Formulacion topica para promover la curacion de heridas. |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US10758584B2 (es) |
| EP (1) | EP3484457B1 (es) |
| JP (2) | JP7538599B2 (es) |
| KR (1) | KR102362362B1 (es) |
| CN (3) | CN119112915A (es) |
| DK (1) | DK3484457T3 (es) |
| ES (1) | ES2955844T3 (es) |
| FI (1) | FI3484457T3 (es) |
| HR (1) | HRP20230726T1 (es) |
| HU (1) | HUE062184T2 (es) |
| LT (1) | LT3484457T (es) |
| MX (1) | MX385380B (es) |
| MY (1) | MY193312A (es) |
| PH (1) | PH12019500126A1 (es) |
| PL (1) | PL3484457T3 (es) |
| PT (1) | PT3484457T (es) |
| RS (1) | RS64356B1 (es) |
| RU (1) | RU2750286C2 (es) |
| SA (1) | SA519400913B1 (es) |
| SG (1) | SG11201900408RA (es) |
| SI (1) | SI3484457T1 (es) |
| TW (1) | TWI746597B (es) |
| WO (1) | WO2018014805A1 (es) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7172438B2 (ja) * | 2018-10-24 | 2022-11-16 | ライオン株式会社 | 水性眼科用組成物及び保存効力向上方法 |
| CN111297877A (zh) * | 2019-12-31 | 2020-06-19 | 中国药科大学 | 积雪草苷或其类似物的制药用途 |
| KR102583283B1 (ko) * | 2021-04-15 | 2023-09-27 | 주식회사 엘지생활건강 | 고함량의 센텔라아시아티카 정량추출물을 포함하는 안정한 화장료 조성물 |
| CN113209007B (zh) * | 2021-05-17 | 2022-11-25 | 海南普利制药股份有限公司 | 积雪苷外用制剂及其制备方法 |
| TW202317167A (zh) * | 2021-06-28 | 2023-05-01 | 合一生技股份有限公司 | 製備到手香萃取物的方法 |
| EP4531841A1 (en) * | 2022-05-27 | 2025-04-09 | Oneness Biotech Co., Ltd. | Plectranthus amboinicus extract for use in inhibiting immune responses |
| CN119604282A (zh) * | 2022-06-27 | 2025-03-11 | 合一生技股份有限公司 | 用于缓解辐射诱导的皮肤病症的到手香提取物 |
| WO2024159451A1 (en) * | 2023-02-01 | 2024-08-08 | Oneness Biotech Co., Ltd. | Plectranthus amboinicus extract for use in scar cosmesis |
| CN117138105B (zh) * | 2023-09-26 | 2025-11-11 | 邯郸惠科新材料科技有限公司 | 一种液体创口贴及其制备方法 |
| US20250195595A1 (en) * | 2023-12-15 | 2025-06-19 | Oneness Biotech Co., Ltd. | Topical formulation for wound healing |
| WO2025199801A1 (zh) * | 2024-03-27 | 2025-10-02 | 合一生技股份有限公司 | 一种治疗受试者肾功能障碍类型的糖尿病足溃疡的组合物 |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2459661A1 (fr) | 1979-06-25 | 1981-01-16 | Phybiocit Laboratoires | Nouvelle composition medicamenteuse a base de plantes, et procede de preparation |
| CN1049122C (zh) | 1993-01-11 | 2000-02-09 | 李厚清 | 复方外伤软膏 |
| DE19581854T1 (de) | 1994-12-03 | 1997-12-04 | Dong Kook Pharmaceutical Co | Asiatsäure-Derivate, Verfahren zu ihrer Herstellung und sie enthaltendes dermatologisches Agens |
| TW299064U (en) | 1995-01-23 | 1997-02-21 | Hitachi Ltd | Resin molded transformer |
| US6267996B1 (en) | 1996-10-17 | 2001-07-31 | Indena S.P.A | Pharmaceutical and cosmetic formulations with antimicrobial activity |
| CN1194154A (zh) | 1997-03-24 | 1998-09-30 | 东国制药株式会社 | 自积雪草的积雪草苷和羟基的积雪草苷和羧基积雪草苷的水溶性提取物及其分离方法 |
| KR100228873B1 (ko) | 1997-03-24 | 1999-11-01 | 강재헌 | 센텔라아시아티카에서 분리한 아시아티코사이드와 마테카소 사이드의 수용성 추출물을 함유한 간세포 및 항간섬유화 치료제 |
| KR20010025178A (ko) * | 1999-08-27 | 2001-04-06 | 체시바사트 위차이 | 푸에라리아 미리피카, 부테아 수페르바 및/또는 무쿠나콜레티 유래의 추출물 및 그 추출방법, 상기 추출물을유효성분으로 함유하는 식품, 음료, 약 및/또는 화장품 및그 제조방법 |
| CN1137681C (zh) | 2000-11-21 | 2004-02-11 | 国家医药管理局上海医药工业研究院 | 积雪甙防粘膜及制备方法 |
| CN1127970C (zh) | 2001-03-14 | 2003-11-19 | 周华国 | 一种治疗烧伤的药膏及其制备方法 |
| US6579543B1 (en) | 2002-02-22 | 2003-06-17 | Jackie H. McClung | Composition for topical application to skin |
| JP2004059482A (ja) | 2002-07-29 | 2004-02-26 | Masahiro Sakanaka | 組織再生促進剤 |
| US20060099283A1 (en) | 2004-11-10 | 2006-05-11 | We Gene Technologies, Inc. | Leaf juice of plectranthus amboinicus for treating cancer and/or tumor |
| CN1682744A (zh) | 2005-03-15 | 2005-10-19 | 天津大学 | 制备积雪草苷巴布剂的方法 |
| TWI361074B (en) | 2005-12-22 | 2012-04-01 | Dev Center Biotechnology | Plant extracts for enhancing healing of wounds,and the preparation process and use thereof |
| TWI320714B (en) | 2006-09-15 | 2010-02-21 | Dev Center Biotechnology | Plant extracts for the treatment of rheumatoid arthritis |
| EP1925310B1 (en) * | 2006-11-24 | 2015-03-25 | Development Center For Biotechnology | Plant extracts from Plectranthus and Centella for treating skin disorders and accelerating wound healing in diabetic patients |
| BRPI0806793B8 (pt) * | 2007-02-12 | 2021-05-25 | Indus Biotech Private Ltd | composição para a inibição seletiva da absorção de serotonina e processo da mesma |
| US8449924B2 (en) * | 2007-08-29 | 2013-05-28 | Development Center For Biotechnology | Process for the preparation of plant extracts for treating skin disorders and enhancing healing of wounds |
| JP4853442B2 (ja) | 2007-09-27 | 2012-01-11 | パナソニック株式会社 | ミストサウナ装置 |
| WO2011103449A2 (en) * | 2010-02-19 | 2011-08-25 | Mary Kay Inc. | Topical skin care formulation |
| CN103079573B (zh) * | 2010-06-10 | 2016-06-15 | 梧桐生物技术私人有限公司 | 用于由积雪草制备高纯度积雪草苷组合物的方法及其应用方法 |
| FR2964570A1 (fr) | 2010-09-09 | 2012-03-16 | Burgundy | Procede de preparation d'un extrait de centella asiatica |
| TWI501772B (zh) * | 2011-11-22 | 2015-10-01 | Oneness Biotech Co | 具抗關節炎活性的到手香精萃物 |
| CN103420967A (zh) | 2013-08-19 | 2013-12-04 | 南京标科生物科技有限公司 | 一种滨蓟黄素的制备方法 |
| TWI663982B (zh) * | 2013-09-03 | 2019-07-01 | 合一生技股份有限公司 | 到手香萃取物用於製備具抗微生物功效組合物之用途 |
| EP3189837B1 (en) | 2014-09-05 | 2023-11-15 | Oneness Biotech Co., Ltd. | Use of flavonoid compound in preparation of composition for healing wound |
-
2017
- 2017-07-17 WO PCT/CN2017/093118 patent/WO2018014805A1/en not_active Ceased
- 2017-07-17 CN CN202411084363.8A patent/CN119112915A/zh active Pending
- 2017-07-17 US US15/651,337 patent/US10758584B2/en active Active
- 2017-07-17 TW TW106123820A patent/TWI746597B/zh active
- 2017-07-17 RS RS20230554A patent/RS64356B1/sr unknown
- 2017-07-17 CN CN201780009172.7A patent/CN108778262A/zh active Pending
- 2017-07-17 HU HUE17830439A patent/HUE062184T2/hu unknown
- 2017-07-17 CN CN202411084307.4A patent/CN119112914A/zh active Pending
- 2017-07-17 SI SI201731369T patent/SI3484457T1/sl unknown
- 2017-07-17 SG SG11201900408RA patent/SG11201900408RA/en unknown
- 2017-07-17 PL PL17830439.0T patent/PL3484457T3/pl unknown
- 2017-07-17 MX MX2019000769A patent/MX385380B/es unknown
- 2017-07-17 FI FIEP17830439.0T patent/FI3484457T3/fi active
- 2017-07-17 PT PT178304390T patent/PT3484457T/pt unknown
- 2017-07-17 KR KR1020197004556A patent/KR102362362B1/ko active Active
- 2017-07-17 RU RU2019104255A patent/RU2750286C2/ru active
- 2017-07-17 HR HRP20230726TT patent/HRP20230726T1/hr unknown
- 2017-07-17 LT LTEPPCT/CN2017/093118T patent/LT3484457T/lt unknown
- 2017-07-17 MY MYPI2019000107A patent/MY193312A/en unknown
- 2017-07-17 DK DK17830439.0T patent/DK3484457T3/da active
- 2017-07-17 ES ES17830439T patent/ES2955844T3/es active Active
- 2017-07-17 EP EP17830439.0A patent/EP3484457B1/en active Active
- 2017-07-17 JP JP2019502066A patent/JP7538599B2/ja active Active
-
2019
- 2019-01-15 SA SA519400913A patent/SA519400913B1/ar unknown
- 2019-01-17 PH PH12019500126A patent/PH12019500126A1/en unknown
-
2022
- 2022-08-04 JP JP2022124798A patent/JP7469400B2/ja active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12019500126A1 (en) | Topical formulation for promoting wound healing | |
| EP3638349A4 (en) | DEVICES FOR ADMINISTERING AN ACTIVE SUBSTANCE AND METHOD OF USING THEREOF | |
| NZ731029A (en) | An antimicrobial composition | |
| CO7240372A2 (es) | Formulaciones farmacéuticas tópicas no acuosas | |
| MX2019014772A (es) | Formulaciones en gel de bisfosfocinas y usos de estas. | |
| CL2017000394A1 (es) | Composición que contiene cineol para la administración nasal | |
| MX2015015197A (es) | Vendaje para herida que comprende una composicion antimicrobiana. | |
| CL2020001273A1 (es) | Emulsiones para el tratamiento tópico de infecciones dérmicas y de infecciones de mucosas. | |
| CO2017007316A2 (es) | Formulación farmacéutica | |
| WO2015003082A3 (en) | Volatile organic compound formulations having antimicrobial activity | |
| MX2019014449A (es) | Composiciones antimicrobianas con bajo contenido de alcohol y que se pueden esterilizar y usos de estas. | |
| MX2014015199A (es) | Formulacion de pexiganan estable. | |
| PH12019502145A1 (en) | Agent for preventing myopia, treating myopia, and/or preventing myopia progression comprising tiotropium as active ingredient | |
| MX378402B (es) | Composiciones para aplicaciones topicas que comprenden peroxido de benzoilo y adapaleno. | |
| BR112018005268A2 (pt) | nanopartículas não vesiculares altamente estáveis e aplicação das mesmas no tratamento de infecção microbiana” | |
| PH12018501991A1 (en) | Pharmaceutical composition for use in treating fibrosis | |
| WO2019059549A3 (ko) | 베타글루칸을 유효성분으로 하는 숙취 해소용 조성물 또는 알코올성 간질환 예방, 개선 또는 치료용 조성물 | |
| SG11201907124YA (en) | Anti-inflammatory agent | |
| WO2014137231A3 (en) | Totarol extract formulations and uses thereof | |
| MX2016009567A (es) | Composicion antifungica. | |
| MX2017008879A (es) | Composicion farmaceutica para el tratamiento de la micosis. | |
| WO2014127022A3 (en) | Mineral feed-through formulation | |
| UA122333U (uk) | Склад лікарського препарату протигрибкової, протимікробної та кератолітичної дії | |
| MY192143A (en) | A skin whitening cosmetic formulation | |
| HK40015879A (en) | Agent for preventing myopia, treating myopia, and/or preventing myopia progression comprising tiotropium as active ingredient |